fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Cadila Healthcare Ltd

Cadila Healthcare Ltd

Updated on January 20, 2020

Stock/Share Code - CADILAHC

Cadila Healthcare is one of the leading, innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain of innovation (research & development), manufacturing, ...Read more

Below is the details of CADILAHC Cadila Healthcare Ltd

Market Cap₹26,018 Cr.
Current Price ₹260.95 as on 10 Dec 19
52 Week High / Low Price₹370 / ₹206.45
Face Value₹1
Stock P/E19.53
Book Value₹90.85
Dividend Yield1.38 %
ROCE16.98 %
ROE18.28 %
Sales Growth (3yrs)-2.62 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has been maintaining a healthy dividend payout of 34.91%
Cons: Stock is trading at 2.80 times its book value The company has delivered a poor growth of 9.94% over past five years. Tax rate seems low Earnings include an other income of Rs.530.70 Cr.

Cadila Healthcare Ltd Price Chart

Cadila Healthcare Ltd Price Chart

Cadila Healthcare Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹170.05 24.93 ₹107,934.08 Cr. 0.61 ₹1,064.09 Cr. 57.62 17.09 8123.35 11.19
2. Dr Reddy's Labs ₹2,897.5 17.68 ₹48,412.38 Cr. 0.69 ₹1,106.8 Cr. 113.54 26.07 4812.80 12.42
3. Cipla ₹453.05 22.78 ₹37,626.53 Cr. 0.64 ₹474.5 Cr. 25.85 9.57 4395.78 10.94
4. Piramal Enterp. ₹1,611.6 17.30 ₹36,008.74 Cr. 1.43 ₹554.69 Cr. 17.26 14.61 3603.56 9.42
5. Biocon ₹289.65 43.30 ₹33,798 Cr. 0.18 ₹215.7 Cr. -24.60 19.02 1572.20 13.39
6. Torrent Pharma. ₹13.65 37.89 ₹32,128.11 Cr. 0.90 ₹244 Cr. 36.31 5.86 2005.00 12.66
7. Aurobindo Pharma ₹432.55 9.99 ₹26,361.38 Cr. 0.56 ₹639.86 Cr. 2.69 17.87 5600.47 18.45
8. Cadila Health. 19.53 ₹26,018.42 Cr. 1.38 ₹627.9 Cr. -5.79 2.32 1682.70 16.98

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Cadila Healthcare Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019
Sales7588201,0431,7381,5741,4551,5051,6441,6761,6681,3441,683
YOY Sales Growth %-56.81%-42.58%12.91%138.58%107.52%77.41%44.33%-5.4%6.46%14.62%-10.71%2.32%
Expenses7167598441,0881,1491,0821,1211,1351,2191,2621,1611,217
Material Cost %33.81%33.26%29.34%29.21%28.89%29.38%35.56%31.44%32.07%33.48%34.41%29.33%
Employee Cost %21.33%19.08%17.74%11.4%12.85%16.02%15.83%14.79%14.32%15.17%19.74%15.89%
Operating Profit4361198650424373384509456406183466
OPM %6%7%19%37%27%26%25%31%27%24%14%28%
Other Income5240552674346106410504627408
Interest4-412243253840-16252668
Depreciation685466707879848890889092
Profit before tax2341517262338731536879143233894713
Tax %4%-14%47%28%21%23%16%16%16%23%16%12%
Net Profit224719145030624331066636326279628
EPS in Rs0.214.600.894.392.992.383.036.513.552.560.776.13
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales1,6431,6981,8332,9203,1513,5274,0425,2847,0323,2315,8106,4936,370
Sales Growth %16.22%3.4%7.91%59.33%7.89%11.95%14.59%30.73%33.07%-54.06%79.83%11.75%%
Expenses1,4111,5341,7992,2112,4832,8203,2333,7504,4542,9094,1644,7384,859
Material Cost %38.47%38.26%41.9%29.79%32.91%35.93%35.01%31.25%26.9%31.22%29.19%33.08%%
Manufacturing Cost %6.1%6.38%7.4%6.33%10.4%11.25%10.21%8.57%5.7%10.59%8.25%8.29%%
Employee Cost %10.38%10.63%12.92%14.17%13.79%11.85%12.99%11.49%9.89%19.22%14.22%15.01%%
Other Cost %30.94%35.05%35.94%25.43%21.7%20.92%21.78%19.66%20.85%29.02%20.01%16.59%%
Operating Profit232164347096687078091,5342,5783221,6461,7551,511
OPM %14%10%2%24%21%20%20%29%37%10%28%27%24%
Other Income1593036205723752307185174582208612531
Interest44884332126111424326116488104
Depreciation73839097108117127212221251293350361
Profit before tax2742965206376705319461,4652,5046421,4971,9281,577
Tax %14%10%3%4%2%6%4%13%19%-3%27%17%
Net Profit2362665036106584999041,2712,0386621,0911,6021,332
EPS in Rs2.412.504.815.826.254.878.8211.9719.906.4510.6515.6513.01
Dividend Payout %24%23%14%21%23%31%20%19%16%50%33%22%

Compounded Sales Growth

  • 10 Years:: 14.35%
  • 5 Years:: 9.94%
  • 3 Years:: -2.62%
  • TTM:: 3.10%

Compounded Profit Growth

  • 10 Years:: 18.93%
  • 5 Years:: 11.01%
  • 3 Years:: -9.19%
  • TTM:: -12.73%

Return on Equity

  • 10 Years:: 11.40%
  • 5 Years:: -4.42%
  • 3 Years:: -14.03%
  • 1 Year:: -30.43%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Sep 2019
Share Capital636868102102102102102102102102102102
Equity Capital62.868.268.2102.4102.4102.4102.4102.4102.4102.4102.4102.4102.4
Reserves9911,1651,5541,9882,4552,8093,5284,4236,1746,5167,6438,8549,198
Borrowings7398205945641,2841,7861,5861,4501,2232,9402,8723,0972,935
Other Liabilities5205586888399589291,1091,4441,4241,6331,6131,5091,555
Trade Payables243283.3374345.9284.8360.7461.7671.3899.91112.9869.2717.2681.5
Total Liabilities2,3122,6112,9043,4934,8005,6266,3257,4198,92311,19112,23113,56313,791
Fixed Assets7848379501,0371,2181,4971,5641,7682,1552,3522,6803,0092,968
Gross Block12411358.51556.71732.52016.225112683.73118.93720.53896.34515.75159.4
Accumulated Depreciation437.9502.5586.3675.9798.51013.91119.61350.81565.71544.31835.52150.3
CWIP96117143234312464531367297678659585775
Investments4435955996991,2121,2801,5582,2092,3183,9243,6184,7254,862
Other Assets9901,0611,2121,5242,0582,3852,6723,0754,1544,2375,2735,2445,185
Inventories331349380.8464.5501.2587.2663.5804.3657.5932.91320.71410.41497.5
Trade receivables282.5352.3400.8475.1615.86837221056.11707.39291255.12087.91905.7
Cash Equivalents1925.628.242.4118.391.689.4129.4163.716.8183.8106.3174.5
Loans n Advances357334.1402.1209.8272.1304.6378.4330.8293.9404.3864.8625.1757
Other Assets etc000332550.5718.7819754.31331.71953.91648.81013.8850.5
Total Assets2,3122,6112,9043,4934,8005,6266,3257,4198,92311,19112,23113,56313,791

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity422685865603724458781,0841,954867288629
Profit from operations348.3390.8622.3734.2623666.38641576.42649.6305.11696.91783.2
Working Capital Changes-258.2-7.1-39.7-111.3-229.7-161.3-33.8-235.7-279.4669.8-1114.2-833.6
Taxes paid-43.8-77.5-25.6-63.4-29.4-59.848-257-414.5-111.8-295.2-320.7
Cash from Investing Activity-267-267-249-368-817-709-408-577-1,016-2,48028-526
Fixed Assets Purchased-167.7-175-232.5-303.2-378.4-542.5-282-304.5-572.8-777.4-602.1-658.5
Fixed Assets Sold11.4242.317.75.22.53.22.12.24.334.9
Investments purchased-150.9-151.6-53-99.9-706-135.5-284.9-387.7-153.8-15560-13.6
Investments sold0.2134.10197.40.421.4016.34.6709.6339
Cash from Financing Activity2326-335-178522250-446-387-9231,366-149-180
Proceeds from Borrowings291.271.8218.766.9882.7692.7329.4303.7100.81929.4319.9357.2
Repayment of Borrowings00-444.4-97-162.2-194-528.7-440.2-327.7-212.4-415.5-95.4
Interest Paid00-38.2-32.8-56.5-73.7-73-39.3-17.7-22.4-53.1-82.7
Dividends Paid-50.2-56.4-61.5-102.3-127.8-153.3-153.4-184-572.9-327.10-358.3
Net Cash Flow7731476-142512014-247167-78

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %21%20%27%28%24%15%20%27%38%8%15%17%
Debtor Days63768059717165738910579117
Inventory Turnover4.985.005.026.916.536.486.467.209.624.065.164.75

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Cadila Healthcare Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.